Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. - Wikidata - wikimedia - TriplyDB

Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.

Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.

http://www.wikidata.org/entity/Q34881535

about

Modeling infectious disease dynamics in the complex landscape of global health Rediscovering Pertussis Pertussis models to inform vaccine policy Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia Modelling the long-term dynamics of pre-vaccination pertussis.Immune boosting explains regime-shifts in prevaccine-era pertussis dynamics.Characterization of a Bvg-regulated fatty acid methyl-transferase in Bordetella pertussis.Pathogen evolution and the immunological niche.Resolving pertussis immunity and vaccine effectiveness using incidence time series.Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand.Dynamical crises, multistability and the influence of the duration of immunity in a seasonally-forced model of disease transmission.Small mutations in Bordetella pertussis are associated with selective sweeps.Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination Use of exposure history to identify patterns of immunity to pneumonia in bighorn sheep (Ovis canadensis).Boosting understanding of pertussis outbreaks.Addressing immunization registry population inflation in adolescent immunization rates Combating pertussis resurgence: One booster vaccination schedule does not fit all Estimation of the underlying burden of pertussis in adolescents and adults in Southern Ontario, Canada.Demographic buffering: titrating the effects of birth rate and imperfect immunity on epidemic dynamics.Caspase-1-independent interleukin-1β is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunity A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine.Asymptomatic transmission and the resurgence of Bordetella pertussis.Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013.Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination.Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens.Bordetella pertussis Isolates from Argentinean Whooping Cough Patients Display Enhanced Biofilm Formation Capacity Compared to Tohama I Reference Strain.Self-boosting vaccines and their implications for herd immunity Self-enforcing regional vaccination agreements.Equations of the End: Teaching Mathematical Modeling Using the Zombie Apocalypse.Serum antibody responses to vaccinal antigens in lean and obese geriatric dogs.Can vaccine legacy explain the British pertussis resurgence?Influence of Population Demography and Immunization History on the Impact of an Antenatal Pertussis Program.Toll-like receptor 4 limits transmission of Bordetella bronchiseptica.A critical literature review of health economic evaluations in pertussis booster vaccination.Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around....Perplexities of pertussis: recent global epidemiological trends and their potential causes.Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization.Comparative efficacy of intranasal and injectable vaccines in stimulating Bordetella bronchiseptica-reactive anamnestic antibody responses in household dogs.

P2860

Q24277713-491DD169-E0E0-4ABA-9F40-AC238EE10E89 Q26744793-17006F15-D261-4105-A5B6-9CCE35D7DA4D Q27014700-1B564C08-1C7D-420E-9A86-8CBD5419CF69 Q28730264-F61E7C11-516E-4D58-A8D1-61B9AB02149C Q30526446-C130136C-7EC4-47D0-B24A-A52C3028D5FC Q31132327-305A6A90-AFB1-4780-85B8-30DF6356A375 Q33663300-90328212-07E4-47E0-BD46-85A39E97B397 Q34078369-1E6D60C9-B41B-4384-A0AC-8D3ED6707BFB Q34318319-12E18C08-121F-4A48-AA65-697A4AF51482 Q34345687-6FA40A2F-5433-4F56-ACB6-CBE761AF53B1 Q34354928-7C42D8E5-9044-4583-B565-022B66A11A69 Q34431224-BA0936B6-FC63-4B2F-9F1D-76FB8F2DDC89 Q34516283-C9D2BDF4-C811-410A-AC5E-132017CE702B Q34700743-952547CC-96B7-4028-B0D0-352850450558 Q34937973-5EDD882D-A8B9-4103-A22B-7B07B6D3824C Q35044884-A4180E99-6327-4C8F-A9BD-C8F4A4F4C08F Q35062572-5149D835-717B-4392-B4CF-7046041B82FB Q35078262-2A650404-819D-4886-BEC4-9E285D6481D6 Q35134368-5296A8B9-EAA4-49DA-9A07-934E1E5193AB Q35242597-41754F27-89FA-410C-A2A4-574D82D844A2 Q35533082-025C98E5-0F03-452A-AFEB-B142F98732E5 Q35634111-F26B1F82-13D2-498A-A030-78AEC7E517DD Q35672136-8CBCC346-494C-4C58-97C0-C3E47AC9C069 Q36039358-0BFFBB62-0558-4442-88CB-39FA3B8DD803 Q36143574-CA8E5628-4D20-4515-B8AB-D0388FEE76A3 Q36263931-2B33FEB2-3474-4F34-AF42-34DBADD1107D Q36354539-87509634-E3E8-465C-AFD0-6D9ED8447A02 Q36471228-6A92E366-DF01-4C38-B378-B2BBCE0EF598 Q36596168-9B544B5D-A35E-4368-AAC1-C7E5E2F1FB40 Q36703154-EB2B6B1B-ADB4-4FC8-BBE6-C775224252D2 Q36787410-7E6E89D3-F461-47D2-AECB-C0975F07EED4 Q37377866-C84CE707-4F2E-41B0-9B04-7C52438CB290 Q37410294-0896673A-1AF2-41EE-874F-5B1CEC5E94C2 Q37534202-70C1987F-3568-4574-854B-9E4FE241FEAF Q37978907-2C614427-C8D7-4CEB-800C-C8561E72FFEE Q38068468-1B917694-37CC-4DD6-A2F3-A96C8505643E Q38074502-F0F279A4-DCE3-4EA7-87F7-46D31C2AB3F1 Q38081288-FEEA0DC3-FFF0-4C68-9FF4-27C56FFEB21A Q38630803-DB77934C-656B-4BEC-8558-6DEB5A54B956 Q38650662-7A419EA6-3045-4E6A-B147-B7E04E161D3C

P2860

Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.

http://www.wikidata.org/entity/Q34881535

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Natural immune boosting in per ...... for long-term vaccine failure.

@ast

Natural immune boosting in per ...... for long-term vaccine failure.

@en

Natural immune boosting in per ...... for long-term vaccine failure.

@nl

type

label

Natural immune boosting in per ...... for long-term vaccine failure.

@ast

Natural immune boosting in per ...... for long-term vaccine failure.

@en

Natural immune boosting in per ...... for long-term vaccine failure.

@nl

prefLabel

Natural immune boosting in per ...... for long-term vaccine failure.

@ast

Natural immune boosting in per ...... for long-term vaccine failure.

@en

Natural immune boosting in per ...... for long-term vaccine failure.

@nl

P1433

Q34881535-45F2EBF7-BFBF-4556-8D60-1A4B74EC91CC

P1476

Q34881535-2BF413F9-90C6-4A00-95CC-63143748EF1B

P2093

Q34881535-277D77D8-E8FB-4970-9672-711667EEE961

P2860

Q34881535-008B99E3-39E3-4F08-B212-DFCB17ED93CA

Q34881535-05A5073A-E113-4CDB-B41C-3BA034E54859

Q34881535-0AC49C55-D534-4D9A-B7FD-5AACF69BD40E

Q34881535-0EAED483-E4A5-4879-B969-65C25101A39F

Q34881535-0F202C3B-2E96-4AB6-9A44-0966DD0029B7

Q34881535-139E8D77-B94A-4E94-A7F8-7DF92BB30008

Q34881535-2C075A80-7D1C-428E-91E3-961F84DCC1C2

Q34881535-2E8EAFEA-0FD0-46AB-B2E6-D51659A2230F

Q34881535-34CA9BAA-EAA7-43C5-82EA-9CB3B18F7FA0

Q34881535-3DEBF354-9177-45C7-B0B6-164A5DEB7875

P304

Q34881535-E8BF0705-AD2A-456F-83C3-6A358BEF015B

P31

Q34881535-9BB1B083-04BB-454F-948E-B2772619FD73

P356

Q34881535-7AFB89B4-8F12-4AC2-B665-60045BF6DC4A

P407

Q34881535-7A2BB358-36D6-4470-BA5F-FABEC01309DF

P433

Q34881535-915FC374-9108-44B6-8100-62ABF1CDE54C

P478

Q34881535-F9A5B853-4C5B-48E2-9F50-E981BC099A0D

P50

Q34881535-21982DF8-8BE6-4790-910E-4BFAE6C1DEF2

Q34881535-8423531F-A27E-42A3-98F9-22999A8E1303

P577

Q34881535-A06DEBBB-A30F-44C6-90BA-36742B3E02C1

P5875

Q34881535-9AE92F3D-B9A5-4F59-8F35-6D0E2DEDD48C

P698

Q34881535-02076B6F-B167-4AA1-860F-B4D404F2CBBE

P932

Q34881535-834FEF39-CCF3-4763-9DF3-982408D112EE

P356

PNAS.1014394108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Natural immune boosting in per ...... for long-term vaccine failure

@en

P2093

Jennie S Lavine

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Herd immunity: history, theory, practice

Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends.

Estimating the duration of pertussis immunity using epidemiological signatures.

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Resolving the impact of waiting time distributions on the persistence of measles

A simple model for complex dynamical transitions in epidemics.

Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years

P304

7259-7264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1014394108

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Ottar N. Bjornstad

P577

2011-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50595871

http://www.w3.org/2001/XMLSchema#string

P698

21422281

http://www.w3.org/2001/XMLSchema#string

P932

3084147

http://www.w3.org/2001/XMLSchema#string